Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FM-VP4 begins phase II hypercholesterolemia study

Nov. 4, 2005

Phase II study of Hemopure in lower limb amputation cleared to begin in U.K.

Nov. 4, 2005

Novel microsomal triglyceride transfer protein inhibitor, SLx-4090, identified

Nov. 3, 2005

Ark Therapeutics announces preliminary results from study of Vitor in cachexia

Nov. 3, 2005

New therapeutic agents claimed for metabolic disorders

Nov. 2, 2005

FDA extends Exubera review period

Nov. 2, 2005

Approval of muraglitazar may require new trials

Nov. 2, 2005

MF-101: a safer alternative for hormonal therapy

Nov. 2, 2005

Sankyo discontinue pactimibe studies

Oct. 31, 2005

U.K. phase II trial of Hemopure cleared to begin

Oct. 31, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...